重复培养在严重真菌性角膜炎治疗中的意义
该研究为随机临床试验数据的二次分析,比较第6天真菌培养阳性与阴性的严重丝状真菌性角膜炎患者。培养阳性者角膜穿孔或需治疗性穿透性角膜移植的风险为阴性者的两倍(P=0.002),3个月最佳戴镜矫正视力平均差0.26 logMAR(P=0.001)。作者认为第6天培养结果可用于风险分层并建立新的诊疗标准。
要点
- 第6天培养阳性的严重真菌性角膜炎患者角膜穿孔或需治疗性穿透性角膜移植的风险为阴性者的两倍(P=0.002)。
- 第6天培养阳性者3个月最佳戴镜矫正视力较阴性者平均差0.26 logMAR(P=0.001)。
- 第6天培养阳性对3个月浸润/瘢痕大小(-0.24 mm1;P=0.45)和再上皮化时间(风险比=0.81;P=0.31)无统计学显著预测作用。
核心结论
- 第6天培养结果是治疗严重真菌性角膜炎的独特有价值的临床工具。
- 基于重复培养阳性的风险分层是评估药物治疗反应和识别不良临床结局高风险患者的客观方法。
- 这建立了严重真菌性角膜炎管理的新诊疗标准。
研究设计与样本
- 研究设计为随机临床试验数据的二次分析。
- 研究对象为涂片阳性丝状真菌性角膜溃疡且视力20/400或更差、随后在印度Aravind Eye Care system、尼泊尔Lumbini Eye Hospital或尼泊尔Bharatpur Eye Hospital进行第6天真菌培养的患者。
- 采用向后逐步回归,协变量包括所有基线临床特征,比较第6天真菌培养阳性与阴性患者的临床结局。
主要发现
- 第6天培养阳性患者发生角膜穿孔或需治疗性穿透性角膜移植的风险为阴性者的两倍(P=0.002),即使控制基线溃疡特征后仍如此。
- 第6天培养阳性患者3个月最佳戴镜矫正视力平均较阴性者差0.26 logMAR(P=0.001)。
- 第6天培养阳性对3个月浸润/瘢痕大小(-0.24 mm1;P=0.45)或再上皮化时间(风险比=0.81;P=0.31)无统计学显著预测作用。
关键数值与推荐
- 主要结局为角膜穿孔率和/或需治疗性穿透性角膜移植。
- 次要结局包括3个月最佳戴镜矫正视力、3个月浸润和/或瘢痕大小、再上皮化率。
临床怎么用
- 作者认为第6天培养结果可用于风险分层,评估对药物治疗的反应,并识别不良临床结局高风险患者。
- 作者认为这建立了严重真菌性角膜炎管理的新诊疗标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify fungal keratitis patients who are at risk of a poor outcome and may benefit from closer follow-up or more aggressive treatment. DESIGN: Secondary analysis of randomized clinical trial data. METHODS: We compared the clinical outcomes of patients who had positive 6-day fungal cultures with those who did not, using backward stepwise regression with covariates for all baseline clinical characteristics. SUBJECTS: Patients presenting with a smear-positive filamentous fungal ulcer and visual acuity of 20/400 or worse, and who subsequently had a 6-day fungal culture performed at the Aravind Eye Care system (India), Lumbini Eye Hospital (Nepal), or Bharatpur Eye Hospital (Nepal). MAIN OUTCOME MEASURES: The primary outcome is rate of corneal perforation and/or the need for therapeutic penetrating keratoplasty. Secondary outcomes include 3-month best spectacle-corrected visual acuity (BSCVA), 3-month infiltrate and/or scar size, and rate of re-epithelialization. RESULTS: Patients who tested positive at their 6-day culture had twice the hazard of experiencing a corneal perforation or the need for therapeutic penetrating keratoplasty (P = .002) than those who tested negative, even after controlling for baseline ulcer characteristics. These patients also had on average 0.26 logMAR lines worse BSCVA at 3 months (P = .001). Culture positivity at day 6 was not a statistically significant predictor of 3-month infiltrate/scar-size (-0.24 mm1; P = .45) or time to re-epithelialization (hazard ratio = .81; P = .31). CONCLUSIONS: Here we identify a uniquely valuable clinical tool, day 6 culture results, for the treatment of severe fungal keratitis. Risk stratification based on repeat culture positivity is an objective way to assess response to medical therapy and identify patients who are at high risk of a poor clinical outcome. This establishes a new standard of care for severe fungal keratitis management.
引用
- Ray KJ, Prajna NV, Lalitha P, et al. The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis. Am J Ophthalmol. 2018. PMID: 29438654. doi:10.1016/j.ajo.2018.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。